Reports Q1 revenue $70,000 vs. $191, 000 last year."We are pleased to have successfully completed the sale of our real estate asset located in Newark NJ during the first quarter of fiscal 2023, and believe that our strong balance sheet provides us the opportunity to focus on strategic business development efforts. Our goal is to acquire, in-license or invest in clinical stage assets with the potential to achieve meaningful milestones, which, if successful, could improve the lives of patients and generate value for our shareholders," said Bill Conkling, CEO of Rafael Holdings.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RFL:
